Webcast - Highlights from SABCS20

The management of breast cancer is rapidly evolving. New data was shared during the San Antonio Breast Cancer Symposium (SABCS 2020) in December 2020. A one-size-fits-all approach to treat breast cancer is insufficient, and there is a need for personalized medicine based on patient and disease characteristics. A number of potentially practice-changing abstracts were presented at SABCS 2020, a major international breast cancer meeting. This enduring educational activity features in-depth discussions and analysis of the latest scientific findings and practice-changing advances in breast cancer treatment. Expert faculty place key abstract findings from SABCS 2020 annual meeting into clinical context and discuss how the results may change the current standard of care. 

This online enduring material offers education to augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:

  • Integrating predictive and/or prognostic markers in management of breast cancer
  • Current and evolving paradigms in the treatment of breast cancer
  • Trends, challenges, and controversies in the management of breast cancer

REGISTRATION FEES: 

Registration is free for healthcare providers who are NOT employees of ACCME defined ineligible companies (An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients).

Please proceed to registration and select "non-industry learner" if you are a healthcare provider involved in patient care and are not an employee of an ineligible company. Your fee will reset to $0.00.

If you are an employee of an ineligible company, please select "industry representative" and pay the industry registration fee when registering for this course.

Target Audience

  • Oncologists

  • Residents/Fellows

  • NPs/PAs

  • Pharmacists

  • Nurses

Learning Objectives

  • Identify the role of novel molecular abnormalities, prognostic markers, and risk factors in breast cancer pathogenesis, risk of recurrences, and their implications on breast cancer prevention and management.
  • Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of breast cancer.

  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact breast cancer management.

  • Review the application of emerging evidence into treatment paradigms for the treatment of breast cancer.

Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 2.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.50 Contact Hours.
Course opens: 
02/22/2021
Course expires: 
02/20/2022
Cost:
$1.00

30-minute Recording: Updates in basic and translational research - Dr. Mark Pegram

30-minute Recording: Updates in ER+ breast cancer/Q&A Session - Dr. Hannah Linden

30-minute Recording: Update in Her2+ breast cancer - Dr. Alvaro Moreno Aspitia

45-minute Recording: Updates in TNBC – Dr. Roberto Leon Ferre

30-minute Recording: Case Presentations - Dr. Siddhartha Yadav

 

 

Mark Pegram, MD

Professor of Medicine

Stanford University, Palo Alto, CA

Learn more

Siddhartha Yadav, MD

Hematologist/Medical Oncologist

Mayo Clinic, Rochester, MN

Learn more

Fengting Yan, MD, PhD

Hematologist/Medical Oncologist

Swedish Cancer Institute, Seattle, WA

Learn more

Hannah Linden, MD

Professor of Medicine

University of Washington, Seattle, WA

Learn more

Roberto Leon-Ferre, MD

Hematologist/Medical Oncologist

Mayo Clinic, Rochester, MN

Learn more

Alvaro Moreno Aspitia, MD, FAAP, FACP

Associate Professor of Medicine

Mayo Clinic, Rochester, MN

Learn more

 


No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity with the exception of the following faculties:

  • Dr. Mark Pegram: Consultant- Roche/Genentech, Novartis, Pfizer, AstraZeneca & Daiichi Sankyo.
  • Dr. Hannah Linden: Research support/Grant – Eisai, Sanofi, Zentalis & Zionexa
  • Dr. Roberto Leon-Ferre: Consultant: AstraZeneca

All relevant financial relationships of individuals in control of the content have been identified and mitigated.  

DISCUSSION OF OFF LABEL PRODUCTS:

If any part of this activity includes the discussion of unapproved or investigational products, faculty discussing those products will clearly identify the product as investigational or not approved. 

The following faculty will discuss off label or investigational products: Roberto Leon-Ferre, MD


Disclosure of commercial support:

This activity is supported with an independent education grant from Merck Sharp & Dohme Corp.

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 2.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.


NURSING CONTACT HOURS 

Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.5 Contact Hours.


ABSM MAINTENANCE OF CERTIFICATE RECOGNITION STATEMENT: 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 2.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 2.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.50 Contact Hours.

Price

Cost:
$1.00
Please login or register to take this course.

Registration Fees:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

 

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you have signed up for the activity but are not able to complete.